HER2-positiver Brustkrebs: Was kommt in der Drittlinie?
Crossref DOI link: https://doi.org/10.1007/s15015-018-3934-x
Published Online: 2018-04-06
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Heim, Thomas
Text and Data Mining valid from 2018-04-01
Article History
First Online: 6 April 2018